Cargando…

Clinical experience with power-injectable PICCs in intensive care patients

INTRODUCTION: In the ICU, peripherally inserted central catheters (PICCs) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome with the use o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pittiruti, Mauro, Brutti, Alberto, Celentano, Davide, Pomponi, Massimiliano, Biasucci, Daniele G, Annetta, Maria Giuseppina, Scoppettuolo, Giancarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396261/
https://www.ncbi.nlm.nih.gov/pubmed/22305301
http://dx.doi.org/10.1186/cc11181
_version_ 1782238090997268480
author Pittiruti, Mauro
Brutti, Alberto
Celentano, Davide
Pomponi, Massimiliano
Biasucci, Daniele G
Annetta, Maria Giuseppina
Scoppettuolo, Giancarlo
author_facet Pittiruti, Mauro
Brutti, Alberto
Celentano, Davide
Pomponi, Massimiliano
Biasucci, Daniele G
Annetta, Maria Giuseppina
Scoppettuolo, Giancarlo
author_sort Pittiruti, Mauro
collection PubMed
description INTRODUCTION: In the ICU, peripherally inserted central catheters (PICCs) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome with the use of power-injectable catheters. METHODS: We retrospectively reviewed all of the power-injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. RESULTS: We collected 89 power-injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related bloodstream infection. Non-infective complications during management were not clinically significant. There was one episode of symptomatic thrombosis during the stay in the ICU and one episode after transfer of a patient to a non-intensive ward. CONCLUSION: Power-injectable PICCs have many advantages in the ICU: they can be used as multipurpose central lines for any type of infusion including high-flow infusion, for hemodynamic monitoring, and for high-pressure injection of contrast media during radiological procedures. Their insertion is successful in 100% of cases and is not associated with significant risks, even in patients with coagulation disorders. Their maintenance is associated with an extremely low rate of infective and non-infective complications.
format Online
Article
Text
id pubmed-3396261
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33962612012-07-13 Clinical experience with power-injectable PICCs in intensive care patients Pittiruti, Mauro Brutti, Alberto Celentano, Davide Pomponi, Massimiliano Biasucci, Daniele G Annetta, Maria Giuseppina Scoppettuolo, Giancarlo Crit Care Research INTRODUCTION: In the ICU, peripherally inserted central catheters (PICCs) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome with the use of power-injectable catheters. METHODS: We retrospectively reviewed all of the power-injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. RESULTS: We collected 89 power-injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related bloodstream infection. Non-infective complications during management were not clinically significant. There was one episode of symptomatic thrombosis during the stay in the ICU and one episode after transfer of a patient to a non-intensive ward. CONCLUSION: Power-injectable PICCs have many advantages in the ICU: they can be used as multipurpose central lines for any type of infusion including high-flow infusion, for hemodynamic monitoring, and for high-pressure injection of contrast media during radiological procedures. Their insertion is successful in 100% of cases and is not associated with significant risks, even in patients with coagulation disorders. Their maintenance is associated with an extremely low rate of infective and non-infective complications. BioMed Central 2012 2012-02-04 /pmc/articles/PMC3396261/ /pubmed/22305301 http://dx.doi.org/10.1186/cc11181 Text en Copyright ©2012 Pittiruti et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Pittiruti, Mauro
Brutti, Alberto
Celentano, Davide
Pomponi, Massimiliano
Biasucci, Daniele G
Annetta, Maria Giuseppina
Scoppettuolo, Giancarlo
Clinical experience with power-injectable PICCs in intensive care patients
title Clinical experience with power-injectable PICCs in intensive care patients
title_full Clinical experience with power-injectable PICCs in intensive care patients
title_fullStr Clinical experience with power-injectable PICCs in intensive care patients
title_full_unstemmed Clinical experience with power-injectable PICCs in intensive care patients
title_short Clinical experience with power-injectable PICCs in intensive care patients
title_sort clinical experience with power-injectable piccs in intensive care patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396261/
https://www.ncbi.nlm.nih.gov/pubmed/22305301
http://dx.doi.org/10.1186/cc11181
work_keys_str_mv AT pittirutimauro clinicalexperiencewithpowerinjectablepiccsinintensivecarepatients
AT bruttialberto clinicalexperiencewithpowerinjectablepiccsinintensivecarepatients
AT celentanodavide clinicalexperiencewithpowerinjectablepiccsinintensivecarepatients
AT pomponimassimiliano clinicalexperiencewithpowerinjectablepiccsinintensivecarepatients
AT biasuccidanieleg clinicalexperiencewithpowerinjectablepiccsinintensivecarepatients
AT annettamariagiuseppina clinicalexperiencewithpowerinjectablepiccsinintensivecarepatients
AT scoppettuologiancarlo clinicalexperiencewithpowerinjectablepiccsinintensivecarepatients